ERYTHROMYCIN ABSORPTION IN HEALTHY-VOLUNTEERS FROM SINGLE AND MULTIPLE DOSES OF ENTERIC-COATED PELLETS AND TABLETS

被引：16

作者：

HOVI, T

JOSEFSSON, K

RENKONEN, OV

机构：

[1] ASTRA LAKEMEDEL AB,CLIN RES,INFECT,S-15185 SODERTALJE,SWEDEN

[2] UNIV HELSINKI,DEPT VIROL,SF-00170 HELSINKI 17,FINLAND

[3] UNIV HELSINKI,DEPT BACTERIOL & IMMUNOL,SF-00170 HELSINKI 17,FINLAND

来源：

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 1983年 / 25卷 / 02期

关键词：

D O I：

10.1007/BF00543802

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：271 / 273

页数：3

共 9 条

[1]

BERGAN T, 1982, CURR THER RES CLIN E, V32, P597

[2]

CHUN AH, 1977, INFECTION S1, V2, P14

[3] INFLUENCE OF STUDY DESIGN IN ASSESSING FOOD EFFECTS ON ABSORPTION OF ERYTHROMYCIN BASE AND ERYTHROMYCIN STEARATE [J].

DISANTO, AR ;

CHODOS, DJ .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1981, 20 (02) :190-196

[4]

GROVE DC, 1955, ASSAY METHODS ANTIBI, P31

[5] DOSE-RELATED PHARMACOKINETICS AFTER ORAL-ADMINISTRATION OF A NEW FORMULATION OF ERYTHROMYCIN BASE [J].

JOSEFSSON, K ;

BERGAN, T ;

MAGNI, L .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 13 (05) :685-691

[6] PHARMACOKINETICS OF A NEW, MICROENCAPSULATED ERYTHROMYCIN BASE AFTER REPEATED ORAL DOSES [J].

JOSEFSSON, K ;

STEINBAKK, M ;

BERGAN, T ;

MIDTVEDT, T ;

MAGNI, L .

CHEMOTHERAPY, 1982, 28 (03) :176-184

[7] STUDIES ON ABSORPTION OF A NEWLY DEVELOPED ENTERIC-COATED ERYTHROMYCIN BASE [J].

MCDONALD, PJ ;

MATHER, LE ;

STORY, MJ .

JOURNAL OF CLINICAL PHARMACOLOGY, 1977, 17 (10) :601-606

[8] INFLUENCE OF FOOD ON THE BIOAVAILABILITY OF NEW FORMULATIONS OF ERYTHROMYCIN STEARATE AND BASE [J].

RUTLAND, J ;

BEREND, N ;

MARLIN, GE .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 8 (04) :343-347

[9] EFFECT OF DISSOLVING PH OF ENTERIC COATING AGENT ON BIOAVAILABILITY OF ENTERIC COATED TABLETS OF ERYTHROMYCIN IN MAN [J].

WATANABE, Y ;

SANO, M ;

MOTOHASHI, K ;

YONEDA, R .

YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 1978, 98 (08) :1092-1100

← 1 →